12th Apr 2007 09:22
ABCAM Plc12 April 2007 For immediate release 12 April 2007 ABCAM PLC ("Abcam" or "the Company") Shareholding Cambridge UK, 12 April 2007: Abcam plc announces that in accordance with theFSA's Disclosure and Transparency Rules, the Company has been notified that, asat 20 March 2007, Unicorn Asset Management Limited had an indirect interest invoting rights over 2,758,823 ordinary shares of 1p each in the Company amountingto approximately 8.0% of the issued share capital of the Company. For further information please contact: Abcam + 44 (0) 1223 696000 Jonathan Milner, Chief Executive Officer Eddie Powell, Chief Financial Officer www.abcam.com Numis Securities + 44 (0) 20 7776 1500 James Black Buchanan Communications + 44 (0) 20 7466 5000 Mark Court / Mary-Jane Johnson Notes for editors: About Abcam plc Abcam is a producer and distributor of research-grade antibodies headquarteredin Cambridge, UK, with a US office located in Cambridge, Massachusetts. Abcamwas admitted to AIM in November 2005 and trades under the ticker symbol ABC.The Company produces and distributes its own and third party produced antibodiesto academic and commercial users throughout the world with product informationprovided and ordering available through the Company's website, www.abcam.com.The antibodies are sold under the Abcam brand name. The Company's vision is tobuild the largest online antibody resource in the world while also ensuring thatthe antibodies are of high quality and commercially viable. Abcam now has anonline catalogue of approximately 29,000 products, most of which are antibodies,from over 200 suppliers supported by up-to-date and detailed technical datasheets, which are created by the Company. The Company currently employs 120staff in its three operating companies. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
ABC.L